According to the information released by the Center for Food Evaluation, State Administration for Market Regulation and the Special Food Information Query Platform, in 2025, State Administration for Market Regulation issued a total of 2130 health food (dietary supplement) registration approvals. Among them, 200 approvals were for new health food products, including 194 domestic products and 6 imported products.
CIRS conducted a detailed summary of these 200 new products, and analyzed from the following points.
1. The Overall Situation of Health Food Registration Approvals Announced in 2025
Among the 2130 registration approvals, 200 are new products, accounting for 9.39% of the total; 243 are products for technology transfer, accounting for 11.41% of the total. The other 1687 registration approvals, not for new products, possibly are renewal registration and change registration.
2. The Number of Approved Products in Different Countries/Regions
Among the 200 approved new products, domestic products are from 25 provinces (municipalities and/or autonomous regions). Beijing ranked first with 46 products, accounting for 23.71% of the total domestic new products. Imported products are from Hong Kong, China (4 products), Indonesia (1 product), and Singapore (1 product).
Note: If the applicant includes more than one enterprises and comes from different provinces, each province is included in the statistics.
3. Enterprises Obtaining Health Food Registration Certificates
Beijing Jinpingkang Pharmaceutical Technology Co., Ltd. obtained 7 new product registration approvals in 2025, taking the top position, followed closely by its parent company, Beijing Century Health Care Pharmaceutical Technology Co., Ltd., which obtained 5 new product registration approvals.
Of the 6 imported products, 4 were from WRIGHT LIFE PHARMACEUTICAL LIMITED, while the remaining 2 came from PT. HELMIGS PRIMA SEJAHTERA and HSIEHS BIOTECH, respectively. Refer to the table below for details.
Table1. Information for imported products approved in 2025
Product Name
Approval Number
Applicant
Country (region) of Production
Health Function
WRIGHT LIFE NOTOGINSENG AND PANAX QUINQUEFOLIUS CAPSULES
国食健注J20250001
WRIGHT LIFE PHARMACEUTICAL LIMITED
Hong Kong, China
Aids in enhancing immunity
HELMIG’S CURCUMIN TABLET
国食健注J20250002
PT. HELMIGS PRIMA SEJAHTERA
Indonesia
Aids in maintaining healthy blood lipid levels & Providing auxiliary protective action against chemical liver damage
WRIGHT LIFE GANODERMA SPORE CAPSULES
国食健注J20250003
WRIGHT LIFE PHARMACEUTICAL LIMITED
Hong Kong, China
Aids in enhancing immunity
WRIGHT LIFE BLUEBERRY LUTEIN CAPSULES
国食健注J20250004
WRIGHT LIFE PHARMACEUTICAL LIMITED
Hong Kong, China
Alleviating visual fatigue
WRIGHT LIFE AGARICUS BLAZEI GANODERMA CAPSULES
国食健注J20250005
WRIGHT LIFE PHARMACEUTICAL LIMITED
Hong Kong, China
Aids in enhancing immunity
GOLDEN LYPRES
国食健注J20250006
HSIEHS BIOTECH
Singapore
Aids in enhancing immunity
4. The Number of Approved Products with Different Dosage Forms
The dosage forms of approved new products (including imported products) include capsule, tablet, powder, oral liquid, etc. Among them, hard capsule products received the largest number of approvals, with the number of 61, followed by tablet products, with the number of 40.
5. The Number of Approved Products with Different Health Functions
5.1 Single health function
As shown in Fig.5-1, there are totally 187 new products (including imported products) approved with a single health function. Among them, products with the health function of “Aids in enhancing immunity” received the largest number of approvals, with the number of 71.
5.2 Two health functions
Except for those new products with single health function, there are also 13 products approved with two health functions (shown in Fig.5-2).
6. CIRS Comments
1) Fewer in quantity, but higher in quality
The stringent technical review and on-site inspection limit the number of approved new products to only a few hundred each year, thereby ensuring their safety and quality from the source. Unlike the health food filing products, thousands of which are approved each year, the registration products are fostering a “fewer but better” market model. Under this model, enterprises focus on health functions that are more targeted and closely aligned with societal health needs when developing new products. This approach enhances product value and competitiveness, enabling enterprises to command a premium even amid pricing pressure from filing products.
2) Imported products bring new vitality
The six imported products approved in 2025 broke the seven-year silence of “zero approval”. This not only serves as a booster for foreign enterprises—signaling that China’s health food market remains open to imported products that comply with regulatory requirements, but also serves as a reminder to domestic companies—with new imported products entering the market, competition will intensify, and the key to respond is to explore and strengthen differentiated advantages.
In 2025, GB 17405-1998 Good Manufacturing Practice for Health Food, that has been in force for over two decades, updated for the first time. The new national standard will take effect on 2 September 2026. It refines requirements about indicator settings and management systems to better protect consumer health, foster industry development, and guide regulatory practice.
Note: There may be a lag in the data release of the Special Food Information Query Platform. The data in this article is only for reference, and the actual situation is subject to the official announcement.
Data Source:
Special Food Information Query Platform of State Administration for Market Regulation (SAMR) and new approval announcements.
If you need any assistance or have any questions, please get in touch with us via service@cirs-group.com.
We have launched a LinkedIn newsletter to keep you up to date on the latest developments across the chemical industry including food and FCMs and personal and home care.
